
Advances in genetic research are transforming cancer diagnosis, and treatments that are tailored to the specific molecular changes that drive tumor growth are now being developed. Because most cancers result from several genetic mutations, NCI is focusing on developing diagnostic tests that identify a number of genetic markers that can be used to predict a person’s response to specific therapies and inform treatment decisions for these diseases.